New York Cancer & Blood Specialists

East Setauket, New York 11733

0 studies enrolling now · 2 studies all time

What they study most

Metastatic Castrate Resistant Prostate Cancer (mCRPC), Metastatic Hormone-Sensitive Prostate Cancer (mHSPC), Paroxysmal Nocturnal Hemoglobinuria

Studies at this site

• The Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPC — Completed
• Study to Evaluate the Efficacy and Safety of APL-2 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) — Completed